In a filing, Pacira BioSciences Inc revealed its Chief Medical Officer SLONIN JONATHAN unloaded Company’s shares for reported $80117.0 on Jul 02 ’24. In the deal valued at $28.25 per share,2,836 shares were sold. As a result of this transaction, SLONIN JONATHAN now holds 95,557 shares worth roughly $1.94 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, WILLIAMS KRISTEN sold 7,452 shares, generating $211,488 in total proceeds. Upon selling the shares at $28.38, the Chief Administrative Officer now owns 102,912 shares.
Before that, GAUGLER DARYL sold 1,000 shares. Pacira BioSciences Inc shares valued at $28,380 were divested by the Chief Operating Officer at a price of $28.38 per share. As a result of the transaction, GAUGLER DARYL now holds 116,040 shares, worth roughly $2.36 million.
Barclays downgraded its Pacira BioSciences Inc [PCRX] rating to an Equal weight from a an Overweight in a research note published on July 03, 2024; the price target was decreased to $25 from $38. Raymond James began covering PCRX with “an Outperform” recommendation on December 20, 2023. TD Cowen revised its rating on August 03, 2023. It rated PCRX as “an Outperform” which previously was an “a Market perform”.
Price Performance Review of PCRX
On Monday, Pacira BioSciences Inc [NASDAQ:PCRX] saw its stock jump 1.62% to $20.35. Over the last five days, the stock has gained 0.72%. Pacira BioSciences Inc shares have fallen nearly -39.67% since the year began. Nevertheless, the stocks have fallen -43.66% over the past one year. While a 52-week high of $40.16 was reached on 01/08/24, a 52-week low of $19.34 was recorded on 07/19/24. SMA at 50 days reached $26.08, while 200 days put it at $28.63. A total of 0.83 million shares were traded, compared to the trading of 0.97 million shares in the previous session.
Levels Of Support And Resistance For PCRX Stock
The 24-hour chart illustrates a support level at 19.87, which if violated will result in even more drops to 19.39. On the upside, there is a resistance level at 20.64. A further resistance level may holdings at 20.93. The Relative Strength Index (RSI) on the 14-day chart is 35.01, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.45, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 65.82%. Stochastics%K at 26.32% indicates the stock is a holding.
